VetClick
Menu Menu
Login

VetClick

/ News
Tuesday, 19th March 2024 | 3,980 veterinary jobs online | 101 people actively seeking work | 5,477 practices registered

Veterinary Industry News

Send us your news

Help Recruiting Dogs For EPIC Study

13 years ago
5562 views

Posted
21st February, 2011 13h06


Do you know an EPIC dog? Veterinary surgeons are being called on to help recruit dogs for a clinical study called EPIC – the Evaluation of Pimobendan In dogs with Cardiomegaly caused by pre-clinical mitral valve disease (MVD). The long-term study, which is supported by Boehringer Ingelheim, will assess whether using pimobendan in the pre-clinical phase of MVD has a benefit in extending the time to the onset of clinical signs. It involves 36 centres globally with the aim of recruiting 360 dogs in total. In order for dogs to be eligible for the study they must:The three veterinary cardiologists from the UK involved in the randomised, double-blinded, placebo-controlled, parallel group study are Adrian Boswood MA VetMB DipECVIM-ca DVC MRCVS from the Royal Veterinary College (the RVC) in Hertfordshire, Sarah Smith MA VetMB DVC MRCVS from Sarah Smith Cardiology in Derbyshire and Mark Patteson MA VetMB, PhD DVC CertVR MRCVS from Heart Vets at Vale Referrals, Gloucestershire. Adrian Boswood, veterinary cardiologist from RVC commented: “The implications of this study for dogs and their owners could be enormous. If the research shows that pimobendan is effective before clinical signs of MMVD appear, this could lead to a new treatment option for practitioners.” For further information on the study or if you have a dog that may be suitable for the trial, please contact the nearest study investigator – Adrian Boswood on 01707 666605, Sarah Smith on 07515 359241 or Mark Patteson on 01453 547934.

More from


You might be interested in...